Med-tech's giants go on hunt for deals: Medtronic and other leaders turn to acquisitions as they seek their next blockbuster products (Star Tribune - Minn)
An Ernst & Young report released last fall said "strategic buyers have become much more risk averse and are increasingly interested in buying assets that have already gained market acceptance and demonstrated growth potential. In the U.S., the 'sweet spot' for attracting buyers now appears to be $40 million to $100 million in sales and a clear path to profitability."
This lack of regulatory predictability has sent venture funding --...
The Orthopedics Industry 
